Table: begin end state 1 12 non-cytoplasmic 13 35 transmembrane 36 40 cytoplasmic 41 61 transmembrane 62 71 non-cytoplasmic 72 94 transmembrane 95 115 cytoplasmic 116 150 transmembrane 151 152 non-cytoplasmic 153 186 transmembrane 187 190 cytoplasmic 191 191 transmembrane 192 193 cytoplasmic 194 196 non-cytoplasmic 197 197 cytoplasmic 198 217 transmembrane 218 223 cytoplasmic 224 245 transmembrane 246 246 cytoplasmic 247 251 non-cytoplasmic 252 269 transmembrane 270 301 cytoplasmic 302 321 transmembrane 322 322 cytoplasmic 323 326 non-cytoplasmic 327 327 cytoplasmic 328 330 transmembrane 331 331 non-cytoplasmic 332 346 transmembrane 347 348 non-cytoplasmic 349 351 transmembrane 352 370 non-cytoplasmic 371 392 transmembrane 393 409 cytoplasmic 410 429 transmembrane 430 433 non-cytoplasmic 434 459 transmembrane 460 530 cytoplasmic 531 550 transmembrane 551 556 non-cytoplasmic
Input: >PP_4735 PP_4735 L-lactate permease MQTWQQLYSPLGSLGLSALAAVIPIVFFFLALAVFRLKGHVAGSITLALSILVAIFAFQM PVDMALAAAGYGFLYGLWPIAWIIVAAVFLYKLTVKSGQFEVIRSSVLSITDDQRLQVLL IGFCFGAFLEGAAGFGAPVAITAALLVGLGFNPLYAAGLCLIANTAPVAFGALGIPIIVA GQVTGIDAFHIGAMTGRQLPLLSLFVPFWLVFMMDGLRGVKETWPAALVAGLSFAVTQYF TSNFIGPELPDITSALASLICLTLFLKVWQPKRAFSEAKGSVGAAVVQPSGSQPSPYSFG EIFKAWSPFLILTVLVTIWTLKPFKAAFAPGGAMYNFVFNFAIPHLDQLVIKTAPIVAAP TAMPAVFKLDPISATGTAIFLSALISMAVLKINFKTGLTTFKETFWELRWPILSIGMVLA FAFVTNYSGMSSTMALVLAGTGAAFPFFSPFLGWLGVFLTGSDTSSNALFSSLQATTAHQ IGVNDTLLVAANTSGGVTGKMISPQSIAVACAATGLVGKESDLFRFTVKHSLFFATIVGL ITLVQAYWLTGMLVHH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server